Previous studies suggested SNAP25 as a biomarker in Alzheimer’s disease (AD), with reduced levels in AD26, as well as for Creutzfeldt-Jacob Disease patients27. This evidence concerns the gene SNAP25 and early-onset autosomal dominant Alzheimer disease.